📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort. (2018)

First Author: Turner RM

Attributed to: MICA: Applying innovative technologies to improve benefit-risk ratio of drugs: developing a national resource underpinned by the MRC Centre for CDSS funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jpba.2018.06.062

PubMed Identifier: 30005242

Publication URI: http://europepmc.org/abstract/MED/30005242

Type: Journal Article/Review

Volume: 159

Parent Publication: Journal of pharmaceutical and biomedical analysis

ISSN: 0731-7085